News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nutra Pharma Corp. (NPHC) Announces Designer Diagnostics Inc.' Clinical Trials to Be Conducted at National Jewish Medical and Research Center



5/2/2007 12:03:12 PM

BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, has today announced that its wholly owned medical devices subsidiary, Designer Diagnostics, will conduct clinical trials for its Tuberculosis (TB) and NonTuberculosis Mycobacterium (NTM) diagnostic Test Kits at National Jewish Medical and Research Center in Denver, Colorado.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES